The Centers for Disease Control and Prevention’s advisory committee voted to approve COVID-19 vaccine boosters for kids between the ages of 5 and 11. The vote took place days after the Food and Drug Administration authorized Pfizer’s booster for kids in that age range. (USA Today)

FDA Commissioner Robert Califf said the baby formula shortage should ease ‘within days.’ Califf told a House of Representatives subcommittee that consumers will feel relief soon thanks to increased output from manufacturers and President Biden’s decision to invoke the Defense Production Act. (NBC News)

The U.S. government placed a $119 million order for 13 million freeze-dried Monkeypox vaccines. The order was made after the first confirmed case of Monkeypox in the U.S. was announced Wednesday. (Fortune)

Pharma companies were urged to develop early plans for averting shortages. The FDA’s draft guidance outlines steps that sponsors of drug or biologic applications should take to develop risk management plans that could limit the impacts of quality issues. (Bloomberg

What’s behind the cult of pharmaceutical decor? During the pandemic, pharmaceutical decor became a popular way for people to destigmatize life-saving medication or glamorize prescription drugs, depending on who you ask. (Dwell)